A scientific gamechanger

Editing along ethical boundaries

Editing along ethical boundaries

Commercially available since 2012, CRISPR-Cas9 (CRISPR) edits genes by cutting DNA and letting natural processes repair those divides. This allows scientists to add, remove or alter particular parts of an organism’s genome. Think of it as a geneticist’s “copy and paste” tool. More precise and inexpensive than previous genome engineering, the attributes that make it widespread in the scientific community also expedite the need for ethical consensus among users.

“What happens when the preventive interventions you imagine raise the same kinds of ethical questions that enhancements do?” asked Eric JuengstOpens in new window, director of the UNC Center for Bioethics. “Questions about equal access, effects on the downstream generations, and effects on what it means to be human.”

Juengst explores these and other ethical quandaries as they relate to this gene-editing tool. His work focuses on research ethics — questions raised by new advances in science and technology. He and his colleague, Jean Cadigan, are leading a project that will survey scientists about the professional and social factors that shape the trajectories of using CRISPR in preventive human genome editing, as well as analyzing national and international policy.

Read the complete Carolina Story…Opens in new window

UNC Health Funding Priorities

Readers Also Viewed...


Working Together Successfully

Carolina's expertise in HIV research provides hope for tackling COVID-19.


Creating Better Days During the Pandemic

Useful findings on resilience and happiness


Protecting Pediatric Patients

Creating pediatric masks for UNC Health

Jessica Lin

Addressing the COVID-19 infection rate of household members

A study led by Jessica Lin, an infectious disease researcher at UNC, is addressing the COVID-19 infection rate of household members.


Lending a Helping Hand

Physician assistant studies student using 3D printing to enhance PPE during COVID-19


From the Frontlines

Wesley Burks, M.D., dean of UNC School of Medicine, vice chancellor for medical affairs and CEO of UNC Health, shares how students, faculty and researchers are responding to the COVID-19 pandemic.